NeuBase Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBSE and other ETFs, options, and stocks.

About NBSE

NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. 

CEO
Dietrich A. Stephan
CEODietrich A. Stephan
Employees
33
Employees33
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2009
Founded2009
Employees
33
Employees33

NBSE Key Statistics

Market cap
12.75M
Market cap12.75M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
67.36K
Average volume67.36K
High today
$0.435
High today$0.435
Low today
$0.395
Low today$0.395
Open price
$0.4176
Open price$0.4176
Volume
61.12K
Volume61.12K
52 Week high
$4.40
52 Week high$4.40
52 Week low
$0.38
52 Week low$0.38

NBSE Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Dec 22, Pre-Market
ActualExpected Dec 22, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.